A study published in JAMA Network Open found that a clinical decision support system (CDSS) for chronic kidney disease (CKD) does not enhance physician behavior or patient outcomes compared to a control intervention.
A recent study conducted by Xizi Zheng and colleagues at Peking University First Hospital in Beijing has revealed that a clinical decision support system (CDSS) for chronic kidney disease (CKD) does not improve physician behavior or patient outcomes when compared to a control intervention. The phase 1 analysis, which included data from the initial six-month follow-up period (June 10 to December 10, 2023), involved 3,390 patients with CKD from 30 primary care centers. These centers were randomly assigned either to an intervention group that received a CDSS embedded into their electronic health records or a control group.
At the six-month follow-up, both groups showed parallel improvements in the use of renin-angiotensin-aldosterone system inhibitors, sodium-dependent glucose transporter 2 inhibitors, and low-density lipoprotein cholesterol control. However, there were no significant differences between the intervention and control groups in these areas. The study also found that neither group saw improvements in blood pressure or glycated hemoglobin levels.
The researchers observed an increase in CKD diagnosis rates by 21.4 percentage points in the intervention group and 27.9 percentage points in the control group, though this difference was not statistically significant. Despite these changes, no substantial differences were noted between the two groups regarding clinical outcomes for CKD management.
"Based on our findings," the authors write, "it appears that targeted education and policy support remain essential foundational elements in primary care settings with suboptimal baseline conditions. However, CDSS should be designed to integrate dynamic feedback mechanisms and interruptive alerts to optimize its effectiveness."
This study underscores the need for further research into more effective strategies for managing chronic kidney disease within primary care settings. The findings suggest that while education remains critical, additional targeted interventions are necessary to address the complex challenges faced by patients with CKD.
Publication details: Xizi Zheng et al., "Clinical Decision Support for Chronic Kidney Disease in Primary Care," JAMA Network Open (2026).
Key medical concepts: Chronic Kidney Disease Decision Support Systems Clinical Sodium-Glucose Transporter 2 Inhibitors
Clinical categories: Nephrology Family Medicine
